Labiotech.eu

affimed afmd 2015 results immuno oncology

News and Trends 31 Mar 2016

The ‘Formative Year’ of Germany’s only NASDAQ-listed Biotech

Affimed from Heidelberg had a ‘formative year’ (hmm) in 2015. Major highlights include raising of €52.6M, expanding to the US and advances in the development of its next-generation antibodies for immuno-oncology. Affimed is a Biopharma focused on discovering and developing highly targeted cancer immunotherapies. It is also one of our trendiest NASDAQ-listed European Biotechs (and the only one […]

March 31, 2016 - 2 minutesmins - By Denise Neves Gameiro

immunocore uveal melanoma trial imcgp100

News and Trends 31 Mar 2016

Money Magnet Immunocore kicks off Trial for Eye Melanoma

Immunocore (UK) has enrolled its first patient for a phase I trial that will test its ImmTAC as a standalone therapy for uveal melanoma, the most common eye cancer. Immunocore is famous for having raised the biggest European Private round ever (€300M), and so it’s no wonder that if often makes our tops here at […]

March 31, 2016 - 2 minutesmins - By Denise Neves Gameiro

plant technologies greentech sundew biotech pat1

News and Trends 31 Mar 2016

From Anti-Ageing Creams to Alzheimer’s, this Biotech ‘Milks’ Tropical Plants

What if a biotech company would run its business with plants as raw materials? We looked at the biotech Plant Advanced Technologies (PAT) (France) aims to push back the frontiers of plant ‘sourcing’, by producing industrial biomolecules in plants without killing them! Only a few thousand of plants are quite well exploited in green biotech over around 450,000 […]

March 31, 2016 - 6 minutesmins - By Nicolas Sainte-Foie

News and Trends 30 Mar 2016

German Biotech targets China for Lung Cancer Liquid Biopsies

Epigenomics (Germany and US) has closed a deal to develop and commercialize a new blood-based lung cancer diagnostic in China, one of its highest performing markets. There are many biotech efforts to find treatments for cancer, but a separate strategy to lower cancer mortality is to improve diagnosis – so that people can be treated when […]

March 30, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 30 Mar 2016

Dutch Startup gets €7M for New Cancer Immunotherapy Platform

Gadeta has raised €7M in a series A round, which will fuel the clinical development of its novel TCR platform, starting with a leukemia cell therapy trial. Gadeta is a spin-out of immuno-oncology research at the University Medical Center Utrecht (UMC Utrecht). It was founded in 2015 by the researchers and Utrecht Holdings, the technology transfer […]

March 30, 2016 - 2 minutesmins - By Denise Neves Gameiro

gairdner awards biomedical research crispr hiv

News and Trends 29 Mar 2016

The CRISPR ‘Crew’ continues World Tour of Scientific Prize Collection

CRISPR remains in the spotlight as the scientific discovery of the century. A long list of ‘inventors’ have been awarded the Canada Gairdner Awards, which recognise innovative biomedical research. The Gairdner Foundation (Canada) has chosen its 2016 picks for the ‘world’s best and brightest’ research in the biomedical sciences. The lucky winners this year work […]

March 29, 2016 - 4 minutesmins - By Denise Neves Gameiro

News and Trends 29 Mar 2016

Belgian Cell Therapy Biotech Excelling in Trials to Treat Severe Osteoporosis

Bone Therapeutics (Belgium) has released its financial results for 2015, which show a solid cash position and promising results in treating Bone conditions in ongoing clinical trials. This Belgian Biotech is developing cell therapies to treat a bone diseases like osteoporosis with considerable success so far – and 2015 was a year with plenty of important milestones. These […]

March 29, 2016 - 3 minutesmins - By Denise Neves Gameiro

philipp hemme labiotech conference novartis sachs biotech markus goebel

News and Trends 29 Mar 2016

Interviewing the Managing Director of the $750M Venture Fund of Novartis

This is last interview you will see from SACHS in Zurich. I met with Markus Goebel, the managing director of the Novartis Venture Fund. He almost played at home as he is living few dozen of kilometres outside the city in the lovely Swiss countryside. Novartis Venture Fund originates, as its name can tell, from […]

March 29, 2016 - 2 minutesmins - By Philip Hemme

synbiobeta infographic synthetic biology europe industry biotec oxitec investors evolva deinove

News and Trends 28 Mar 2016

Infographic: A Handy Guide to the European Synthetic Biology Startup Scene

The rise of Synthetic biology has radicalised how the biotech industry innovates, develops and invests. Here is an infographic put together by SynBioBeta (the ‘Activity hub for the SynBio industry’). Synbio is now an essential source of research, particularly in the Greentech field. For example, Deinove (France) has signed major partnerships with the US on Synbio […]

March 28, 2016 - 2 minutesmins - By Dani Bancroft

News and Trends 25 Mar 2016

Israeli Pharma gets FDA Approval for New Antibody against Severe Asthma

Teva (Israel) can now commercialize their intravenous drug (Cinqair) in the US, which will help adults with severe asthma. Based near Tel Aviv, Teva is the largest producer of generics, but it is also conducting its own biotech research. These include collaborations with Active Biotech (Sweden) for treatment of Huntington’s disease, and Heptares Therapeutics […]

March 25, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 25 Mar 2016

Biotech of the Week: OSE Pharma, the ‘Significant’ Immunotherapy Player from Paris

This week, we head up full speed from Geneva with our eyes aiming towards Paris. Known for its beauty, bohemian lifestyle and, of course the Eiffel Tower, the Louvre and le baguette, Paris is also the home of OSE Pharma, our Biotech of the Week. City: Paris (France) Founded: 2012 Employees: N/A Financial Data: €24.3M total raised (as of […]

March 25, 2016 - 2 minutesmins - By Joachim Eeckhout

News and Trends 24 Mar 2016

Endeavouring to Establish Europe’s Largest MedTech Fund

The VC Endeavour Vision (Switzerland) has finally closed its Endeavour Medtech Growth (EMG) at €250M. This makes it one of the largest funds dedicated to MedTech innovation worldwide! Largely oversubscribed, the fund reached its hard cap and closed well above its €150M target, finally reaching €250M – the largest fund dedicated to medtech in Europe, and one of the largest pure […]

March 24, 2016 - 2 minutesmins - By Dani Bancroft

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The ‘Formative Year’ of Germany’s only NASDAQ-listed Biotech

Money Magnet Immunocore kicks off Trial for Eye Melanoma

From Anti-Ageing Creams to Alzheimer’s, this Biotech ‘Milks’ Tropical Plants

German Biotech targets China for Lung Cancer Liquid Biopsies

Dutch Startup gets €7M for New Cancer Immunotherapy Platform

The CRISPR ‘Crew’ continues World Tour of Scientific Prize Collection

Belgian Cell Therapy Biotech Excelling in Trials to Treat Severe Osteoporosis

Interviewing the Managing Director of the $750M Venture Fund of Novartis

Infographic: A Handy Guide to the European Synthetic Biology Startup Scene

Israeli Pharma gets FDA Approval for New Antibody against Severe Asthma

Biotech of the Week: OSE Pharma, the ‘Significant’ Immunotherapy Player from Paris

Endeavouring to Establish Europe’s Largest MedTech Fund

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!